1.96
Precedente Chiudi:
$2.04
Aprire:
$2.07
Volume 24 ore:
73,069
Relative Volume:
0.38
Capitalizzazione di mercato:
$6.74M
Reddito:
$895.50K
Utile/perdita netta:
$-26.30M
Rapporto P/E:
-1.1951
EPS:
-1.64
Flusso di cassa netto:
$-23.84M
1 W Prestazione:
-7.98%
1M Prestazione:
+42.03%
6M Prestazione:
-62.16%
1 anno Prestazione:
-85.41%
Mainz Biomed N V Stock (MYNZ) Company Profile
Nome
Mainz Biomed N V
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MYNZ con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MYNZ
Mainz Biomed N V
|
1.96 | 7.78M | 895.50K | -26.30M | -23.84M | -1.64 |
![]()
TMO
Thermo Fisher Scientific Inc
|
484.96 | 180.56B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
202.94 | 147.13B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
566.50 | 45.45B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
119.54 | 34.14B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
197.76 | 33.86B | 15.50B | 1.33B | 2.16B | 7.34 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-02-14 | Iniziato | Maxim Group | Buy |
2024-11-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
2023-11-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2022-06-21 | Iniziato | H.C. Wainwright | Buy |
Mainz Biomed N V Borsa (MYNZ) Ultime notizie
What is Mainz Biomed N.V. company’s growth strategyPost Market Review For 2025 - jammulinksnews.com
What institutional investors are buying Mainz Biomed N.V. stockTop Growth Opportunities For Fast Growth - jammulinksnews.com
How does Mainz Biomed N.V. compare to its industry peersExplosive wealth accumulation - jammulinksnews.com
What is the risk reward ratio of investing in Mainz Biomed N.V. stockCapitalize on market trends with expert guidance - jammulinksnews.com
What catalysts could drive Mainz Biomed N.V. stock higher in 2025Achieve superior returns through strategic trading - jammulinksnews.com
Why Mainz Biomed N.V. stock attracts strong analyst attentionHigh Return Investment Tips - Metal.it
What is the dividend policy of Mainz Biomed N.V. stockBuild wealth steadily with smart trading - jammulinksnews.com
How strong is Mainz Biomed N.V. company’s balance sheetFree Stock Market Return Analysis - jammulinksnews.com
Why is Mainz Biomed N.V. stock attracting strong analyst attentionHigh-yield trading alerts - jammulinksnews.com
What institutions are buying Mainz Biomed N.V. stock nowFree Stock Market Swing Trading Strategies - Metal.it
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com
Does Mainz Biomed N.V. stock pay reliable dividendsRapid capital growth - jammulinksnews.com
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - jammulinksnews.com
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
Mainz Biomed, CARE announce collaboration agreement - TipRanks
Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire
Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan
When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com
What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com
Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com
Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World
Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire
What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser
Mainz Biomed N V Azioni (MYNZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):